Casdin Capital, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$21,807,000
-44.9%
2,211,622
-39.4%
0.65%
-44.6%
Q4 2020$39,566,000
+39.7%
3,650,000
+32.7%
1.17%
-7.6%
Q3 2020$28,325,000
-27.3%
2,750,000
+47.5%
1.27%
-45.0%
Q2 2020$38,941,000
+254.3%
1,865,000
+65.8%
2.30%
+97.5%
Q1 2020$10,991,000
+531.7%
1,125,000
+275.0%
1.17%
+281.4%
Q1 2018$1,740,000
+53.4%
300,000
-28.6%
0.31%
-54.3%
Q1 2017$1,134,000420,0000.67%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders